NASDAQ:CLRB

Cellectar Biosciences Stock Predictions

Healthcare > Biotechnology

Buy CLRB

*Your capital is at risk

$2.60

-0.140 (-5.11%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CLRB Prediction Chart

CLRB Predictions History

Latest community submissions for CLRB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 21, 2017	$2.38 -99.08%	$2.59	V	91.90%	0
Ron.Boutwell.1883	Feb 15, 2017	$2.25 -99.10%	$2.49	V	90.40%	0
JS Pro	Feb 15, 2017	$2.40 -99.04%	$2.49	X	96.40%	0
Ethan.Carpenter.1142	Sep 30, 2016	$3.23 -98.81%	$2.71	X	80.80%	0
JS Pro	Sep 30, 2016	$3.17 -98.83%	$2.71	X	83.00%	0
PumpTheseNumbers Pro	Sep 30, 2016	$2.71 -99.00%	$2.71	V	100.00%	10
Steven.Geringer.277	Jun 17, 2016	$3.95 -98.91%	$3.64	X	91.50%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLRB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CELLECTAR BIOSCIENCES

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by